NYSE:CVS - CVS Health Stock Price, Price Target & More

Get Started

$66.03 +0.91 (+1.40 %)

(As of 05/27/2018 05:37 AM ET)

Previous Close$66.03

Today's Range$64.94 - $66.53

52-Week Range$60.14 - $84.00

Volume5.56 million shs

Average Volume9.60 million shs

Market Capitalization$67.13 billion

P/E Ratio10.60

Dividend Yield3.03%

Beta1.02

About CVS Health (NYSE:CVS)

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores

Sub-IndustryDrug Retail

SectorRetail/Wholesale

SymbolNYSE:CVS

CUSIP12665010

Webwww.cvshealth.com

Phone401-765-1500

Debt

Debt-to-Equity Ratio1.59

Current Ratio2.37

Quick Ratio1.88

Price-To-Earnings

Trailing P/E Ratio10.60

Forward P/E Ratio9.45

P/E Growth0.99

Sales & Book Value

Annual Sales$184.77 billion

Price / Sales0.36

Cash Flow$8.5865 per share

Price / Cash7.69

Book Value$38.04 per share

Price / Book1.74

Profitability

EPS (Most Recent Fiscal Year)$5.90

Net Income$6.62 billion

Net Margins3.59%

Return on Equity17.45%

Return on Assets6.10%

Miscellaneous

Employees246,000

Outstanding Shares1,016,650,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Tuesday, March 13th. Shareholders of record on Monday, April 23rd will be paid a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date is Friday, April 20th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.39 by $0.09. The pharmacy operator earned $45.69 billion during the quarter, compared to analyst estimates of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The business's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the firm earned $1.17 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

What price target have analysts set for CVS?

19 analysts have issued twelve-month target prices for CVS Health's shares. Their predictions range from $68.00 to $99.00. On average, they expect CVS Health's share price to reach $86.8750 in the next year. View Analyst Ratings for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in May. As of May 15th, there was short interest totalling 45,677,764 shares, an increase of 3.0% from the April 30th total of 44,363,884 shares. Based on an average daily trading volume, of 11,733,063 shares, the short-interest ratio is currently 3.9 days. Approximately 4.5% of the company's stock are short sold.

Who are some of CVS Health's key competitors?

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:

Mr. Larry J. Merlo, CEO & Director (Age 62)
Mr. David M. Denton, Exec. VP & CFO (Age 53)
Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
Mr. Thomas Michael Moriarty, Exec. VP, Chief of Policy & External Affairs Officer and Gen. Counsel (Age 54)
Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

News stories about CVS stock have trended somewhat positive on Sunday, according to Accern. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. CVS Health earned a news sentiment score of 0.19 on Accern's scale. They also assigned media headlines about the pharmacy operator an impact score of 47.37 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are CVS Health's major shareholders?

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.89%), Barrow Hanley Mewhinney & Strauss LLC (1.78%), Northern Trust Corp (1.52%), Franklin Resources Inc. (1.20%), Veritas Asset Management LLP (1.12%) and Dimensional Fund Advisors LP (1.06%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Prudential Financial Inc., Element Capital Management LLC, The Manufacturers Life Insurance Company , Boston Partners, Lord Abbett & CO. LLC, Crawford Investment Counsel Inc. and Equity Investment Corp. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Carmignac Gestion, Barrow Hanley Mewhinney & Strauss LLC, Rockefeller Capital Management L.P., Millennium Management LLC, Russell Investments Group Ltd. and Toronto Dominion Bank. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $66.03.

How big of a company is CVS Health?

CVS Health has a market capitalization of $66.20 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:		3.4 out of 5 ( )
Outperform Votes:		944 (Vote Outperform)
Underperform Votes:		440 (Vote Underperform)
Total Votes:		1,384

MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

CVS Health (NYSE:CVS) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

19 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $86.8750, suggesting that the stock has a possible upside of 31.57%. The high price target for CVS is $99.00 and the low price target for CVS is $68.00. There are currently 6 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.79	2.80	2.80	2.65
Ratings Breakdown:	0 Sell Rating(s) 6 Hold Rating(s) 11 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 12 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 12 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$86.8750	$87.2353	$88.4037	$85.6483
Price Target Upside:	31.57% upside	36.37% upside	25.30% upside	24.09% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/7/2018	Loop Capital	Set Price Target	Hold	$68.00	Medium
4/11/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $88.00	Low
4/10/2018	Leerink Swann	Set Price Target	Buy	$85.00	Low
2/13/2018	Citigroup	Set Price Target	Neutral ➝ Neutral	$80.00 ➝ $77.00	Low
2/9/2018	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$85.00 ➝ $80.00	Low
2/9/2018	Needham & Company LLC	Set Price Target	Strong-Buy ➝ Buy	$100.00 ➝ $98.00	Medium
2/8/2018	Royal Bank of Canada	Set Price Target	Buy	$89.00	Medium
1/24/2018	Mizuho	Set Price Target	Buy	$95.00	Low
1/18/2018	Cowen	Reiterated Rating	Outperform	$81.00 ➝ $99.00	Low
1/5/2018	SunTrust Banks	Boost Price Target	Buy	$90.00	High
1/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$88.00	High
1/4/2018	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$90.00	High
1/4/2018	UBS	Upgrade	Outperform ➝ Strong-Buy		High
12/26/2017	Tigress Financial	Reiterated Rating	Buy		Low
12/5/2017	Deutsche Bank	Reiterated Rating	Buy ➝ Hold		Medium
12/4/2017	Jefferies Group	Set Price Target	Hold	$76.00	Medium
10/9/2017	Oppenheimer	Reiterated Rating	Buy	$95.00	N/A
8/14/2017	Wolfe Research	Downgrade	Outperform ➝ Market Perform	$89.00 ➝ $82.00	Low
7/3/2017	Guggenheim	Reiterated Rating	Buy		Low
5/3/2017	Evercore ISI	Reiterated Rating	Outperform	$87.00 ➝ $88.00	Low
2/6/2017	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$84.00	N/A
12/19/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A
11/10/2016	Argus	Reiterated Rating	Buy	$120.00 ➝ $85.00	N/A
11/9/2016	Barclays	Reiterated Rating	Buy	$85.00	N/A
8/3/2016	FBR & Co	Reiterated Rating	Outperform	$120.00	N/A

(Data available from 5/27/2016 forward)

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.76
2019 EPS Consensus Estimate: $7.13

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	5	$1.10	$1.49	$1.29
Q2 2018	5	$1.43	$1.62	$1.58
Q3 2018	4	$1.69	$1.82	$1.76
Q4 2018	4	$1.99	$2.22	$2.13
Q1 2019	2	$1.24	$1.51	$1.38
Q2 2019	2	$1.59	$1.69	$1.64
Q3 2019	1	$1.78	$1.78	$1.78
Q4 2019	1	$2.33	$2.33	$2.33

CVS Health (NYSE CVS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/8/2018		$1.61					N/A
5/2/2018	Q1 2018	$1.39	$1.48	$45.7746 billion	$45.6930 billion	View	N/A
2/8/2018	Q4 2017	$1.88	$1.92	$47.5388 billion	$48.3850 billion	View	Listen
11/6/2017	Q3 2017	$1.49	$1.50	$46.1740 billion	$46.1810 billion	View	N/A
8/8/2017	Q2 2017	$1.31	$1.33	$45.3553 billion	$45.6850 billion	View	Listen
5/2/2017	Q1 2017	$1.1030	$1.17	$44.2025 billion	$44.5140 billion	View	Listen
2/9/2017	Q416	$1.67	$1.71	$46.56 billion	$46.00 billion	View	Listen
11/8/2016	Q316	$1.57	$1.64	$45.29 billion	$44.60 billion	View	Listen
8/2/2016	Q216	$1.30	$1.32	$44.28 billion	$43.70 billion	View	N/A
5/3/2016	Q116	$1.16	$1.18	$43.01 billion	$43.20 billion	View	N/A
2/9/2016	Q415	$1.53	$1.53	$41.12 billion	$41.15 billion	View	N/A
10/30/2015	Q315	$1.29	$1.28	$37.81 billion	$38.50 billion	View	Listen
8/4/2015	Q215	$1.20	$1.22	$37.18 billion	$37.20 billion	View	N/A
5/1/2015	Q115	$1.08	$1.14	$35.93 billion	$36.30 billion	View	N/A
2/10/2015	Q414	$1.21	$1.21	$36.06 billion	$37.06 billion	View	N/A
11/4/2014	Q314	$1.13	$1.15	$34.74 billion	$35.00 billion	View	N/A
8/5/2014	Q214	$1.10	$1.13	$33.47 billion	$34.60 billion	View	N/A
5/2/2014	Q114	$1.05	$1.02	$32.31 billion	$32.70 billion	View	N/A
2/11/2014	Q413	$1.11	$1.12	$32.67 million	$32.80 million	View	N/A
11/5/2013	Q313	$1.02	$1.05	$31.53 billion	$32.00 billion	View	Listen
8/6/2013	Q2 2013	$0.96	$0.97	$31.13 billion	$31.25 billion	View	Listen
5/1/2013	Q113	$0.79	$0.83	$30.36 billion	$30.76 billion	View	Listen
2/6/2013	Q4 2012	$1.10	$1.14	$31.13 billion	$31.40 billion	View	Listen
11/6/2012	Q312	$0.84	$0.85	$30.0880 billion	$30.2270 billion	View	N/A
8/7/2012		$0.80	$0.81			View	N/A
5/2/2012		$0.63	$0.65			View	N/A
2/8/2012	Q4 2011	$0.89	$0.89			View	N/A
11/3/2011		$0.68	$0.70			View	N/A
8/4/2011		$0.65	$0.65			View	N/A
5/5/2011		$0.55	$0.57			View	N/A
2/3/2011		$0.79	$0.80			View	N/A
11/3/2010	Q3 2010	$0.64	$0.65			View	N/A
7/28/2010	Q2 2010	$0.68	$0.65			View	N/A
5/4/2010	Q1 2010	$0.58	$0.60			View	N/A
2/8/2010	Q4 2009	$0.78	$0.79			View	N/A
11/5/2009	Q3 2009	$0.64	$0.65			View	N/A
8/4/2009	Q2 2009	$0.64	$0.65			View	N/A
5/5/2009	Q1 2009	$0.54	$0.55			View	N/A
2/19/2009	Q4 2008	$0.69	$0.70			View	N/A
10/30/2008	Q3 2008	$0.59	$0.60			View	N/A
7/31/2008	Q2 2008	$0.60	$0.60			View	N/A
5/1/2008	Q1 2008	$0.54	$0.55			View	N/A
1/31/2008	Q4 2007	$0.55	$0.58			View	N/A

(Earnings results data provided by Zacks Investment Research)

CVS Health (NYSE:CVS) Dividend Information

CVS Health pays an annual dividend of $2.00 per share, with a dividend yield of 3.03%. CVS's most recent quarterly dividend payment was Thursday, May 3. The company has grown its dividend for the last 10 consecutive years and is increasing its dividend by an average of 22.10% each year. CVS Health pays out 33.90% of its earnings out as a dividend.

Most Recent Dividend:	5/3/2018
Annual Dividend:	$2.00
Dividend Yield:	3.03%
Dividend Growth:	22.10% (3 Year Average)
Payout Ratio(s):	33.90% (Trailing 12 Months of Earnings) 28.61% (Based on This Year's Estimates) 28.01% (Based on Next Year's Estimates) 23.29% (Based on Cash Flow)
Track Record:	10 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/13/2018	quarterly	$0.50	2.9655990510083%	4/20/2018	4/23/2018	5/3/2018
12/29/2017	quarterly	$0.50	2.72%	1/23/2018	1/24/2018	2/2/2018
9/19/2017	quarterly	$0.50	2.48%	10/23/2017	10/24/2017	11/3/2017
7/6/2017	quarterly	$0.50	2.54%	7/20/2017	7/24/2017	8/3/2017
3/2/2017	quarterly	$0.50	2.47%	4/19/2017	4/21/2017	5/1/2017
12/22/2016	quarterly	$0.50	2.54%	1/20/2017	1/24/2017	2/2/2017
9/22/2016	quarterly	$0.4250	1.88%	10/20/2016	10/24/2016	11/3/2016
7/6/2016	quarterly	$0.4250	1.78%	7/19/2016	7/21/2016	8/1/2016
3/2/2016	quarterly	$0.4250	1.71%	4/20/2016	4/22/2016	5/2/2016
12/16/2015	quarterly	$0.4250	1.79%	1/20/2016	1/22/2016	2/2/2016
10/1/2015	quarterly	$0.35	1.41%	10/20/2015	10/22/2015	11/2/2015
7/8/2015	quarterly	$0.35	1.32%	7/21/2015	7/23/2015	8/3/2015
3/4/2015	quarterly	$0.35	1.35%	4/22/2015	4/24/2015	5/4/2015
12/17/2014	quarterly	$0.35	1.49%	1/20/2015	1/22/2015	2/2/2015
9/24/2014	quarterly	$0.2750	1.38%	10/21/2014	10/23/2014	11/3/2014
7/10/2014	quarterly	$0.2750	1.43%	7/17/2014	7/21/2014	8/1/2014
3/6/2014	quarterly	$0.2750	1.5%	4/17/2014	4/22/2014	5/2/2014
12/18/2013	quarterly	$0.2750	1.57%	1/21/2014	1/23/2014	2/3/2014
9/25/2013	quarterly	$0.2250	1.55%	10/17/2013	10/21/2013	11/1/2013
7/10/2013	quarterly	$0.2250	1.48%	7/18/2013	7/22/2013	8/2/2013
3/6/2013	quarterly	$0.2250	1.73%	4/19/2013	4/23/2013	5/3/2013
12/13/2012	quarterly	$0.2250	1.83%	1/22/2013	1/24/2013	2/4/2013

(Data available from 1/1/2013 forward)

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.53%
Institutional Ownership Percentage: 83.34%

Insider Trading History for CVS Health (NYSE:CVS)

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/4/2018	C David Brown II	Director	Buy	10,000	$61.99	$619,900.00	101,252
2/16/2018	Helena Foulkes	EVP	Sell	19,965	$71.04	$1,418,313.60	65,072
12/21/2017	Lisa Bisaccia	EVP	Sell	29,445	$75.00	$2,208,375.00	15,556
10/2/2017	Thomas M Moriarty	EVP	Sell	20,547	$81.17	$1,667,799.99	43,178
9/18/2017	Jonathan C Roberts	COO	Sell	85,743	$83.14	$7,128,673.02	119,555
9/15/2017	Helena Foulkes	EVP	Sell	39,340	$81.88	$3,221,159.20	84,337
9/13/2017	Larry J Merlo	Insider	Sell	241,150	$83.07	$20,032,330.50	299,255
9/11/2017	David M Denton	CFO	Sell	237,078	$79.65	$18,883,262.70	141,096
9/11/2017	Thomas M Moriarty	EVP	Sell	90,267	$79.61	$7,186,155.87	70,102
8/16/2017	Richard J Swift	Director	Sell	2,500	$79.62	$199,050.00	3,258
6/26/2017	Helena Foulkes	EVP	Sell	20,333	$80.00	$1,626,640.00	59,301
6/19/2017	Helena Foulkes	EVP	Sell	20,332	$76.98	$1,565,157.36	59,300
6/12/2017	David M Denton	CFO	Sell	230,510	$80.00	$18,440,800.00	176,983
3/21/2017	Troyen A Brennan	EVP	Sell	23,849	$78.73	$1,877,631.77	94,309
3/17/2017	Eva C Boratto	EVP	Sell	6,029	$79.60	$479,908.40	41,614
3/13/2017	Andrew Sussman	EVP	Sell	14,104	$80.40	$1,133,961.60	22,801
3/10/2017	David M Denton	CFO	Sell	95,618	$80.68	$7,714,460.24	250,335
2/16/2017	Jonathan C Roberts	EVP	Sell	61,196	$80.00	$4,895,680.00	89,955
5/5/2016	Larry J Merlo	CEO	Sell	38,247	$105.00	$4,015,935.00	280,381
5/5/2016	Troyen A Brennan	EVP	Sell	7,517	$105.00	$789,285.00	69,601
4/1/2016	Stephen J Gold	EVP	Sell	21,922	$105.00	$2,301,810.00	42,048
3/9/2016	Larry J Merlo	CEO	Sell	38,247	$100.00	$3,824,700.00	261,287
2/11/2016	Jonathan C. Roberts	EVP	Sell	23,355	$92.86	$2,168,745.30	75,315
2/1/2016	Larry J. Merlo	CEO	Sell	46,393	$96.14	$4,460,223.02	561,059
1/11/2016	Larry J. Merlo	CEO	Sell	46,393	$95.00	$4,407,335.00	161,613
10/27/2015	Troyen A. Brennan	EVP	Sell	23,603	$105.00	$2,478,315.00	43,858
7/20/2015	Eva C Boratto	SVP	Sell	22,107	$110.34	$2,439,286.38
7/15/2015	Lisa Bisaccia	EVP	Sell	49,908	$110.00	$5,489,880.00
6/1/2015	C David Brown II	Director	Sell	10,000	$102.57	$1,025,700.00
5/1/2015	C David Brown II	Director	Sell	15,000	$100.27	$1,504,050.00
4/10/2015	Andrew Sussman	EVP	Sell	17,638	$102.38	$1,805,778.44
4/2/2015	Troyen A Brennan	EVP	Sell	33,384	$102.48	$3,421,192.32
3/23/2015	Troyen A Brennan	EVP	Sell	33,274	$104.94	$3,491,773.56
3/20/2015	C David Brown II	Director	Sell	25,000	$104.30	$2,607,500.00
1/7/2015	Jonathan C Roberts	EVP	Sell	86,487	$95.31	$8,243,075.97
1/5/2015	Larry J Merlo	CEO	Sell	144,144	$94.30	$13,592,779.20
1/2/2015	Andrew Sussman	SVP	Sell	4,220	$95.67	$403,727.40
1/2/2015	Per Gh Lofberg	EVP	Sell	347,343	$95.28	$33,094,841.04
11/7/2014	Helena Foulkes	EVP	Sell	46,325	$88.06	$4,079,379.50
10/27/2014	Lisa Bisaccia	SVP	Sell	33,507	$85.00	$2,848,095.00
9/2/2014	Andrew Sussman	SVP	Sell	9,020	$79.45	$716,639.00
8/6/2014	J. David Joyner	EVP	Sell	123,516	$76.10	$9,399,567.60
7/21/2014	Eva C Boratto	SVP	Sell	22,107	$76.77	$1,697,154.39
7/1/2014	David M Denton	CFO	Sell	74,989	$75.88	$5,690,165.32
4/2/2014	Eva Boratto	SVP	Sell	17,108	$74.51	$1,274,717.08	6,998
3/31/2014	Troyen Brennan	EVP	Sell	18,867	$74.33	$1,402,384.11	56,187
1/3/2014	David Denton	CFO	Sell	14,113	$70.50	$994,966.50	85,869
1/3/2014	Per Gh Lofberg	EVP	Sell	790,888	$70.54	$55,789,239.52	219,871
1/2/2014	Jonathan Roberts	EVP	Sell	162,192	$70.61	$11,452,377.12	40,563
1/2/2014	Larry Merlo	CEO	Sell	228,875	$70.76	$16,195,195.00	408,649
12/10/2013	Lisa Bisaccia	SVP	Sell	12,057	$68.00	$819,876.00	27,233
11/18/2013	Troyen Brennan	EVP	Sell	35,387	$65.61	$2,321,741.07	56,187
10/18/2013	Eva C Boratto	SVP	Sell	11,053	$60.50	$668,706.50
10/11/2013	Eva Boratto	SVP	Sell	11,053	$59.50	$657,653.50	19,448
9/13/2013	Helena Foulkes	EVP	Sell	53,546	$60.00	$3,212,760.00	7,897
9/9/2013	Helena Foulkes	EVP	Sell	47,568	$58.65	$2,789,863.20
9/4/2013	Andrew Sussman	SVP	Sell	9,020	$58.36	$526,407.20	3,128
10/4/2012	Andrew Sussman	SVP	Sell	9,020	$49.00	$441,980.00
10/1/2012	Thomas M Moriarty	EVP	Buy	6,164	$48.67	$300,001.88
9/13/2012	David M Denton	CFO	Sell	11,526	$47.00	$541,722.00
8/21/2012	Jean Pierre Millon	Director	Sell	33,726	$45.73	$1,542,289.98

(Data available from 1/1/2013 forward)

CVS Health (NYSE CVS) News Headlines

Source:

Date	Headline
	Analyzing CVS Health (CVS) & Rite Aid (RAD) www.americanbankingnews.com - May 26 at 7:56 AM
	Pros and Cons to Buying CVS Health Corp Stock www.msn.com - May 25 at 3:13 PM
	LabCorp expands agreement with Aetna finance.yahoo.com - May 25 at 3:13 PM
	Pfizer to pay $23.85 million to settle U.S. co-payment kickback probe finance.yahoo.com - May 25 at 5:11 AM
	Anthem to Buy Aspire Health for Better Healthcare Service finance.yahoo.com - May 24 at 3:15 PM
	Harvard-born Sundots to sell its sun-protection gummies in CVS finance.yahoo.com - May 24 at 3:15 PM
	Pfizer to pay $23.85 million to resolve U.S. kickback probe finance.yahoo.com - May 24 at 3:15 PM
	Rory McIlroy to pair with Brad Faxon at CVS Health Charity Classic www.msn.com - May 23 at 5:16 AM
	CVS-Aetna, Cigna-Express Scripts Deals Will Consolidate Control Of Medicare Drug Benefits www.forbes.com - May 22 at 3:07 PM
	CVS-Aetna merger is not about the minute clinic, Aetna CEO says finance.yahoo.com - May 22 at 3:07 PM
	Saks Fifth Avenue’s Beauty Business Gets a Big Makeover finance.yahoo.com - May 21 at 3:11 PM
	Comparing CVS Health (CVS) and Rite Aid (RAD) www.americanbankingnews.com - May 20 at 9:53 AM
	Resurgent Economy, Buyouts to Keep Health Insurers Buoyant finance.yahoo.com - May 19 at 5:14 AM
	CVS Health (CVS) Expected to Announce Quarterly Sales of $46.48 Billion www.americanbankingnews.com - May 18 at 2:04 AM
	Health Insurance Industry Outlook - May 2018 www.zacks.com - May 17 at 3:11 PM
	Is CVS Health Corporation (NYSE:CVS) A Smart Pick For Income Investors? finance.yahoo.com - May 17 at 3:11 PM
	Financial Review: CVS Health (CVS) and Diplomat Pharmacy (DPLO) www.americanbankingnews.com - May 17 at 6:06 AM
	$1.51 EPS Expected for CVS Health (CVS) This Quarter www.americanbankingnews.com - May 16 at 7:10 PM
	Moody’s likes the upward financial trend at this Lakeland pharmacy benefits manager finance.yahoo.com - May 16 at 3:16 PM
	UPDATE 1-U.S. hedge funds pile into health insurers, ignore Amazon threat www.cnbc.com - May 16 at 5:02 AM
	Rite Aid-Albertsons: We'll Be Top 5 Health, Food And Wellness Player finance.yahoo.com - May 15 at 3:03 PM
	Trump Health Secretary Says Drugmakers Must Help Cut Prices www.msn.com - May 15 at 5:21 AM
	CVS, Aetna Deal Has a 70% Chance of Closing. Here’s What Happens If It Doesn’t. www.barrons.com - May 15 at 5:21 AM
	Why CVS Health Corp Stock Rallied on Trump's Drug Plan finance.yahoo.com - May 15 at 5:21 AM
	Thinking about buying stock in Apple, CVS Health Corp, Facebook, Symantec and Trade Desk? www.prnewswire.com - May 14 at 3:10 PM
	CVS responds to $40M Fred's deal www.bizjournals.com - May 14 at 3:10 PM
	CVS responds to $40M Fred's deal finance.yahoo.com - May 14 at 3:10 PM
	CVS, Aetna Deal Has a 70% Chance of Closing. Here's What Happens If It Doesn't. finance.yahoo.com - May 14 at 3:10 PM
	Critical Review: CVS Health (CVS) vs. Diplomat Pharmacy (DPLO) www.americanbankingnews.com - May 13 at 11:16 PM
	Why Trump's Big Drug Price Speech Sent Health Care Stocks Soaring fortune.com - May 13 at 3:15 PM
	CVS Health fortune.com - May 12 at 3:05 PM
	Insiders Are Buying CVS on the Cheap -- You Should Too finance.yahoo.com - May 12 at 3:05 PM
	CVS Health (CVS) Comments on Trump Administration Initiative to Reduce Drug Costs www.streetinsider.com - May 12 at 7:34 AM
	Health Investors Rush Back as Trump Drug Speech Fuels Rally www.msn.com - May 12 at 7:34 AM
	[$$] Trump’s Plan to Cut Drug Prices Leaves Industry Relieved finance.yahoo.com - May 12 at 7:34 AM
	Trump Trashes Pharma's Middlemen, but the Stocks Rise finance.yahoo.com - May 12 at 7:34 AM
	[$$] Reckoning for Drug Middlemen Is Postponed, Not Canceled finance.yahoo.com - May 12 at 7:34 AM
	DIGITAL HEALTH BRIEFING: UnitedHealthcare demonstrates benefit of value-based care - Walmart adds employee health tools - CVS partners with chatbot www.msn.com - May 11 at 3:21 PM
	CVS Health Statement on Trump Administration Initiative to Reduce Drug Costs finance.yahoo.com - May 11 at 3:21 PM
	Behind the mega-hospital merger that will make this Northern California health system a $28 billion behemoth www.bizjournals.com - May 11 at 5:20 AM
	We Are Playing The CVS Hand seekingalpha.com - May 11 at 5:20 AM
	Earnings Show CVS Health Corp on Track To Benefit From Transformation investorplace.com - May 11 at 4:09 AM
	CVS Health (CVS) versus Diplomat Pharmacy (DPLO) Financial Analysis www.americanbankingnews.com - May 10 at 7:29 PM
	Should You Buy CVS Health Corporation (NYSE:CVS) At This PE Ratio? finance.yahoo.com - May 9 at 3:13 PM
	Reviewing CVS Health (CVS) & Diplomat Pharmacy (DPLO) www.americanbankingnews.com - May 9 at 11:50 AM
	Trade Mistake 3: CVS Boredom Trade seekingalpha.com - May 9 at 5:10 AM
	CVS Health (CVS) Downgraded by ValuEngine to Strong Sell www.americanbankingnews.com - May 8 at 3:23 PM
	Buoy Health and CVS Health Provide Easy Access to Affordable Care www.bizjournals.com - May 8 at 3:02 PM
	Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More finance.yahoo.com - May 8 at 3:02 PM
	Boston-based Buoy partners with CVS Health for Minute Clinic access www.bizjournals.com - May 8 at 3:02 PM

CVS Health (NYSE:CVS) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

CVS Health (NYSE CVS) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff